Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Enteroviral meningitis causes appreciable morbidity in adults, including hospitalization, decreased activity, and headache. Limited data define the natural history of disease. No antiviral therapeutic agent has demonstrated improved outcome in controlled clinical trials. Pleconaril, an inhibitor of enterovirus replication, was tested in two placebo-controlled clinical trials. Of 607 randomized patients in a multicenter, double-blind placebo-controlled study of pleconaril (200 mg three times daily versus an identical-appearing placebo), 240 patients were confirmed to have enterovirus infection. The time to headache resolution was evaluated by using Kaplan-Meier survival methodology. A Cox regression model evaluated multivariate factors associated with disease resolution. Resolution of headache in patients with concomitant moderate to severe nausea at baseline occurred at a median of 9.5 days in the absence of therapy and was reduced to 7.0 days for pleconaril recipients ( P = 0.009). For a headache score of >5 alone, treated patients resolved headache significantly more rapidly ( P = 0.005). Males resolved headache 50% faster than females. Regardless of randomization group, patients with a baseline headache score of 5 or greater resolved headache 50% more slowly than patients with a baseline headache score of 4. No differences in either clinical or laboratory adverse events were noted. Over 50% of untreated patients had a persistent headache that was greater than 1 week in duration. Pleconaril shortened the course of illness compared to placebo recipients, especially in the early disease course. However, the benefit was achieved only modestly in a subgroup analysis of patients with more severe disease after adjusting for confounding variables.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, enteroviruses have been found to be the underlying cause of most viral meningitis cases worldwide.”
From Viral meningitis: an overview (2021) · cites this paper as [6]
In the citing paper
“Several studies have shown that pleconaril plays an important role in shortening the course of symptoms, especially headache [6, 99]. However, other studies have shown that there was no significant difference between treatment and placebo groups [100].”
From Viral meningitis: an overview (2021) · cites this paper as [6]
In the citing paper
“Similarly, in an analysis based on combined data from two randomized controlled trials of treatment with pleconaril in enteroviral meningitis, females had a longer time to resolution of headaches during admission.24”
From Clinical features and prognostic factors in adults with viral meningitis. (2023) · cites this paper as [24]
Citations
Cites
Treatment of Potentially Life-Threatening Enterovirus Infections with Pleconaril
Rotbart, H. A., Webster, A. D., & for the Pleconaril Treatment Registry Group (2001) · Clinical Infectious Diseases · doi:10.1086/318452 · Cited by 373
Activity of Pleconaril against Enteroviruses
Pevear, D. C., Tull, T. M., Seipel, M. E., & Groarke, J. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2109 · Cited by 368 · cited 3×
“Pleconaril is an orally administered antiviral agent that inhibits enterovirus replication by a capsid-binding mechanism (4).”
BackgroundEnteroviral infections of the central nervous system.
Rotbart, H. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.971 · Cited by 312 · cited 4×
“Study B Nausea 27 (15) 10 (6) Back pain 24 (13) 17 (9) Diarrhea 14 (8) 20 (11) Vomiting 14 (8) 13 (7) Constipation 14 (8) 8 (5) Headache 12 (7) 14 (8) Dizziness 12 (7) 9 (5) Insomnia 9 (5) 9 (5)”
BackgroundInfluentialGender-Associated Differences in Emergency Department Pain Management
Raftery, K. A., Smith‐Coggins, R., & Chen, A. E. (1995) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(95)70107-9 · Cited by 149 · cited 2×
“Study B Nausea 27 (15) 10 (6) Back pain 24 (13) 17 (9) Diarrhea 14 (8) 20 (11) Vomiting 14 (8) 13 (7) Constipation 14 (8) 8 (5) Headache 12 (7) 14 (8) Dizziness 12 (7) 9 (5) Insomnia 9 (5) 9 (5)”
BackgroundDouble blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
ABZUG, M. J., CLOUD, G., BRADLEY, J., SÁNCHEZ, P. J., ROMERO, J., POWELL, D., LEPOW, M., MANI, C., CAPPARELLI, E. V., BLOUNT, S., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000059765.92623.70 · Cited by 138
Self-citationPleconaril: a novel antipicornaviral drug
Romero, J. R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.369 · Cited by 131 · cited 3×
“Study B Nausea 27 (15) 10 (6) Back pain 24 (13) 17 (9) Diarrhea 14 (8) 20 (11) Vomiting 14 (8) 13 (7) Constipation 14 (8) 8 (5) Headache 12 (7) 14 (8) Dizziness 12 (7) 9 (5) Insomnia 9 (5) 9 (5)”
BackgroundGender differences in the experience of headache
Celentano, D. D., Linet, M. S., & Stewart, W. F. (1990) · Social Science & Medicine · doi:10.1016/0277-9536(90)90309-g · Cited by 113 · cited 2×
“Study A Headache 15 (22) 12 (19) Nausea 7 (10) 7 (11) Diarrhea 7 (10) 1 (11) Back pain 6 (9) 5 (8) Vomiting 4 (6) 6 (10) Dyspepsia 2 (3) 8 (13) Constipation 2 (3) 1 (2)”
BackgroundEnterovirus Meningitis in Adults
Rotbart, H. A., Brennan, P. J., Fife, K. H., Romero, J. R., Griffin, J. A., McKinlay, M. A., & Hayden, F. G. (1998) · Clinical Infectious Diseases · doi:10.1086/517162 · Cited by 92 · cited 4×
“Data on the natural history of enteroviral meningitis in adults are limited; however, significant morbidity has been reported, including hospitalization, protracted illness, and impairment of normal activities (8).”
BackgroundInfluentialCirculation of enteroviruses and persistence of meningitis cases in the winter of 1999–2000
Chambon, M., Archimbaud, C., Bailly, J., Henquell, C., Regagnon, C., Charbonné, F., & Peigue‐Lafeuille, H. (2001) · Journal of Medical Virology · doi:10.1002/jmv.2039 · Cited by 59 · cited 3×
“Study A Headache 15 (22) 12 (19) Nausea 7 (10) 7 (11) Diarrhea 7 (10) 1 (11) Back pain 6 (9) 5 (8) Vomiting 4 (6) 6 (10) Dyspepsia 2 (3) 8 (13) Constipation 2 (3) 1 (2)”
BackgroundEnterovirus infections: A review of clinical presentation, diagnosis, and treatment
Stalkup, J. R., & Chilukuri, S. (2002) · Dermatologic Clinics · doi:10.1016/s0733-8635(01)00009-2 · Cited by 51 · cited 2×
“Study A Headache 15 (22) 12 (19) Nausea 7 (10) 7 (11) Diarrhea 7 (10) 1 (11) Back pain 6 (9) 5 (8) Vomiting 4 (6) 6 (10) Dyspepsia 2 (3) 8 (13) Constipation 2 (3) 1 (2)”
Background
Cited by
Solomon, T., Michael, B. D., Smith, P. E., Sanderson, F., Davies, N. W. S., Hart, I. J., Holland, M., Easton, A., Buckley, C., Kneen, R., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2011.11.014 · Cited by 464
“In phase III clinical trials pleconaril reduced symptoms of aseptic meningitis, particularly headache, by approximately two days, compared with placebo controls, but it is not used widely for this condition.(116) The drug has also been used in patients with chronic enterovirus infection due to agammaglobulinaemia, ent…”
McGill, F., Heyderman, R. S., Michael, B. D., Defres, S., Beeching, N. J., Borrow, R., Glennie, L., Gaillemin, O., Wyncoll, D., Kaczmarski, E., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.01.007 · Cited by 254
“Other non-specific symptoms such as diarrhoea, vomiting, muscle pain, and sore throat are sometimes seen.(257) Patients with HSV-2 meningitis rarely have concurrent genital ulcers caused by the virus and often don’t have any history of genital disease.”
BackgroundViral encephalitis: a clinician’s guide
Solomon, T., Hart, I. J., & Beeching, N. J. (2007) · Practical Neurology · doi:10.1136/jnnp.2007.129098 · Cited by 249
Kneen, R., Michael, B. D., Menson, E., Mehta, B., Easton, A., Hemingway, C., Klapper, P. E., Vincent, A., Lim, M., Carrol, E., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2011.11.013 · Cited by 215
Enterovirus infections of the central nervous system
Rhoades, R. E., Tabor-Godwin, J. M., Tsueng, G., & Feuer, R. (2011) · Virology · doi:10.1016/j.virol.2010.12.014 · Cited by 212
“Also, numerous case studies evaluating the efficacy of pleconaril to treat clinically ill patients including immunocompromised individuals have been described (Desmond et al., 2006; Webster, 2005) .”
BackgroundMcGill, F., Griffiths, M. J., Bonnett, L. J., Geretti, A. M., Michael, B. D., Beeching, N. J., McKee, D., Scarlett, P., Hart, I. J., Mutton, K. J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30245-7 · Cited by 193
Enterovirus and parechovirus infection in children: a brief overview
de Crom, S. C. M., Rossen, J. W. A., van Furth, A. M., & Obihara, C. C. (2016) · European Journal of Pediatrics · doi:10.1007/s00431-016-2725-7 · Cited by 192
Kohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
Lee, B. E., & Davies, H. D. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3280ad4672 · Cited by 163
Abzug, M. J., Michaels, M. G., Wald, E., Jacobs, R. F., Romero, J. R., Sánchez, P. J., Wilson, G., Krogstad, P., Storch, G. A., Lawrence, R., et al. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv015 · Cited by 155
“In studies of EV meningitis, EV infections in immunocompromised hosts, and picornavirus upper respiratory tract infections [7–13] and in a phase 1 study in neonates and uncontrolled case reports and case series in newborns [14, 15], pleconaril was generally well tolerated, with suggestion of benefit in some studies.”
BackgroundSelf-citationReplication and Inhibitors of Enteroviruses and Parechoviruses
van der Linden, L., Wolthers, K. C., & van Kuppeveld, F. J. M. (2015) · Viruses · doi:10.3390/v7082832 · Cited by 181
“Pleconaril displays broad-spectrum activity against most, but not all EVs and had some beneficial effects in clinical trials [119–124], but was rejected by the FDA in 2002 for the treatment of the common cold due to safety issues [125].”
BackgroundEnterovirus infections in neonates
Tebruegge, M., & Curtis, N. C. (2009) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2009.02.002 · Cited by 158
Enteroviral infection in neonates
Chuang, Y.-Y., & Huang, Y. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.08.018 · Cited by 152
Update in the Diagnosis and Management of Central Nervous System Infections
Ziai, W., & Lewin, J. J. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.03.013 · Cited by 147
“Patients with life-threatening enterovirus infections have been treated successfully with pleconaril on a compassionate-use basis, and it is deserving of further study [146,147].”
BackgroundAseptic Meningitis and Viral Myelitis
Irani, D. N. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.03.003 · Cited by 139
“In two randomized studies with more than 600 combined patients, pleconaril only modestly shortened the course of the illness in a subgroup of adults with EV meningitis who experienced more severe symptoms and who were treated early in disease [55].”
Parechoviruses in children: understanding a new infection
Harvala, H., Wolthers, K. C., & Simmonds, P. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833890ca · Cited by 138
Viral meningitis: current issues in diagnosis and treatment
McGill, F., Griffiths, M. J., & Solomon, T. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000355 · Cited by 97
Studahl, M., Lindquist, L., Eriksson, B.-M., Günther, G., Bengner, M., Franzen-Röhl, E., Fohlman, J., Bergström, T., & Aurelius, E. (2013) · Drugs · doi:10.1007/s40265-013-0007-5 · Cited by 90
“Pleconaril has been tried and a somewhat shortened duration of symptoms in meningitis was found, and symptoms seemed to be moderated in severe disease [175].”
BackgroundViral meningitis and encephalitis: an update
Gundamraj, V., & Hasbun, R. (2023) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000922 · Cited by 111
“Emerging and re-emerging viruses that have caused endemic or worldwide outbreaks or epidemics are arboviruses (e.g., West Nile virus, Japanese encephalitis, Tick borne encephalitis, Dengue, Zika, Toscana), enteroviruses (e.g., Enterovirus 71, Enterovirus D68), Parechoviruses, respiratory viruses [e.g., severe acute re…”
BackgroundHighlights in Antiviral Drug Research: Antivirals at the Horizon
Clercq, E. D. (2012) · Medicinal Research Reviews · doi:10.1002/med.21256 · Cited by 68
Enteroviral encephalitis in children: clinical features, pathophysiology, and treatment advances
Jain, S., Patel, B., & Bhatt, G. C. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000145 · Cited by 61
Epidemiology and clinical outcomes of viral central nervous system infections
Ben Abid, F., Abukhattab, M., Ghazouani, H., Khalil, O., Gohar, A., Al Soub, H., Al Maslamani, M., Al Khal, A., Al Masalamani, E., Al Dhahry, S., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.06.008 · Cited by 59
Paintsil, E., & Cheng, Y.-C. (2009) · Encyclopedia of Microbiology · doi:10.1016/b978-012373944-5.00178-4 · Cited by 55
Kramer, A. H. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.011 · Cited by 54
Pediatric Group B Coxsackievirus Infections
Romero, J. R. (2008) · Springer eBooks · doi:10.1007/978-3-540-75546-3_10 · Cited by 52
“In contrast, a post hoc evaluation of efficacy of pleconaril for the treatment of meningitis in adults did demonstrate faster resolution of headache in individuals with moderate to severe nausea ( Desmond et al. 2006 ).”
ResultWildenbeest, J., van den Broek, P. J., Benschop, K., Koen, G., Wierenga, P. C., Vossen, A. C. T. M., Kuijpers, T. W., & Wolthers, K. C. (2011) · Antiviral Therapy · doi:10.3851/imp1936 · Cited by 50
“No serious adverse events were noted in treated patients [14,15].”
BackgroundClinical features and prognostic factors in adults with viral meningitis.
Petersen, P. T., Bodilsen, J., Jepsen, M. P. G., Larsen, L., Storgaard, M., Hansen, B. R., Helweg-Larsen, J., Wiese, L., Lüttichau, H. R., Andersen, C. Ø., et al. (2023) · Brain · doi:10.1093/brain/awad089 · Cited by 44
“24 27-29 Since unaccounted factors probably remain in our analyses, these results serve as leverage to further explore the impact of sex and gender on the outcome of viral meningitis.”
Antivirals against Enteroviruses: A Critical Review from a Public-Health Perspective
Benschop, K., van der Avoort, H. G. A. M., Duizer, E., & Koopmans, M. (2015) · Antiviral Therapy · doi:10.3851/imp2939 · Cited by 44
Adverse events following immunization: perception and evidence
Bonhoeffer, J., & Heininger, U. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32811ebfb0 · Cited by 42
Chi, C., Khanh, T. H., Thoa, L. P. K., Tseng, F., Wang, S.-M., Thinh, L. Q., Lin, C.-C., Wu, H., Wang, J., Hùng, N. T., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828a2a85 · Cited by 38
Bodilsen, J., Larsen, L., Brandt, C. T., Wiese, L., Hansen, B. R., Andersen, C. Ø., Lüttichau, H. R., Helweg-Larsen, J., Storgaard, M., & Nielsen, H. (2021) · Clinical Epidemiology · doi:10.2147/clep.s326461 · Cited by 33
Therapeutic Use of Immunoglobulins
Stiehm, E. R., Orange, J. S., Ballow, M. C., & Lehman, H. K. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.08.005 · Cited by 32
“Antiviral therapy with pleconoril has also been used [83].”
MethodEnteroviruses and Parechoviruses
Dunn, J. J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0006-2015 · Cited by 37
Community‐acquired acute meningitis and encephalitis: a narrative review
Beaman, M. H. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.01073 · Cited by 31
Haley, E. S., Au, G. G., Carlton, B. R., Barry, R. D., & Shafren, D. R. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0433-0 · Cited by 25
“Importantly, the broad-spectrum antipicornavirus drug, Pleconaril, shortens the duration of illness in severe cases of enteroviral meningitis [61], thus, following therapeutic EV1 administration, infection may be potentially treated in the case of serious side effects.”
BackgroundTreatment of Neonatal Enterovirus Infections
Modlin, J. F. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv030 · Cited by 23
“given within 2 days of onset [9].”
Enterovirus Meningitis in Adults: A Prospective Nationwide Population-Based Cohort Study
Bodilsen, J., Mens, H., Midgley, S., Brandt, C. T., Petersen, P. T., Larsen, L., Hansen, B. R., Lüttichau, H. R., Helweg-Larsen, J., Wiese, L., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012294 · Cited by 23
Al‐Qahtani, S. M., Shati, A. A., Alqahtani, Y. A., & Ali, A. S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.923125 · Cited by 37
Virus Infections of the Nervous System
Solomon, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-5101-2.00022-4 · Cited by 22
Suzuki, T., Maekawa, K., Matsuo, K., Yamasaki, M., Shibata, M., Takahashi, T., & Naito, Y. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2845-19 · Cited by 22
“Although enterovirus meningitis usually improves within 7-10 days, in our patient meningeal symptoms persisted for approximately two months and the clinical course was atypical for viral meningitis (8).”
BackgroundEpidemiology Profile of Viral Meningitis Infections Among Patients in Qatar (2015–2018)
Mathew, S., Al-Khatib, H. A., Alansari, K., Nader, J. D., Nasrallah, G. K., Younes, N., Coyle, P. V., Thani, A. A. A., Maslamani, M. A. R. S. A., & Yassine, H. M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.663694 · Cited by 29
Infections of the Central Nervous System
Blank, M. J. W., & Tunkel, A. R. (2005) · Wiley eBooks · doi:10.1002/047009057x.ch148 · Cited by 21
Update on Viral Infections Involving the Central Nervous System in Pediatric Patients
Autore, G., Bernardi, L., Perrone, S., & Esposito, S. (2021) · Children · doi:10.3390/children8090782 · Cited by 25
“Another clinical trial on EV meningitis showed only a modest benefit with pleconaril [86].”
BackgroundEncephalitis and Postinfectious Encephalitis
Greenlee, J. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000423847.40147.06 · Cited by 23
“Pleconaril, an antiviral drug that binds to a hydrophobic pocket in the major protein of the enterovirus capsid VP1, has been shown to be of modest benefit in cases of enteroviral CNS infections but is not approved for use in the United States.(32,33)”
Acute and recurrent viral meningitis
Davis, L. E. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0018-9 · Cited by 24
Tunkel, A. R., van de Beek, D., & Scheld, W. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00089-8 · Cited by 27
Neonatal Echovirus 30 Infection Associated With Severe Hepatitis in Twin Neonates
Pino, R., Cortada, A. P., Sanz, M. I., Vidal, X. K., & Muñoz‐Almagro, C. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815b395b · Cited by 17
Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin
Planitzer, C. B., Farcet, M. R., Schiff, R. I., Ochs, H. D., & Kreil, T. R. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21980 · Cited by 17
“While no specific therapy for echovirus infection is available, current clinical treatment regimen still include pleconaril [Abzug et al., 2004; American Academy of Pediatrics, 2006; Desmond et al., 2006].”
BackgroundCongenital echovirus 21 infection causing fulminant hepatitis in a neonate
Pedrosa, C., Lage, M. J., & Virella, D. (2013) · BMJ Case Reports · doi:10.1136/bcr-2012-008394 · Cited by 16
Meningitis gone viral: description of the echovirus wave 2013 in Germany
Graf, J., Hartmann, C. J., Lehmann, H. C., Otto, C., Adams, O., Karenfort, M., Schneider, C. A., Ruprecht, K., Bosse, H. M., Diedrich, S., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4635-6 · Cited by 17
Mostyn, A., Lenihan, M., O’Sullivan, D. M., Woods, S., O'Hara, M., Powell, J., Power, L., O’Connell, N. H., & Dunne, C. P. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100042 · Cited by 24
“[17] who have reported enterovirus as the most common cause of viral meningitis in the United States with an estimated 75,000 cases annually.”
BackgroundViral infections in paediatric patients receiving conventional cancer chemotherapy
Simon, A., Schildgen, O., & Schuster, F. R. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.132225 · Cited by 16
“Prospective studies in children with cancer are still not available.(66) 67”
BackgroundInternationale Klassifikation von Kopfschmerzerkrankungen: 3. Auflage
Göbel, H., & Evers, S. (2019) · Nervenheilkunde · doi:10.1055/a-0930-5739 · Cited by 15
Lindblom, N., Lindquist, L., Westman, J., Åström, M., Bullock, R. A., Hendrix, S. B., & Wahlund, L. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210301 · Cited by 15
“Between 1996 and 2005, more than 4,500 subjects were exposed to it in different clinical trials [65–68] where pleconaril was also shown to slightly shorten the duration of meningitis symptoms [69, 70].”
BackgroundPinkert, S., Dieringer, B., Diedrich, S., Zeichhardt, H., Kurreck, J., & Fechner, H. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.10.010 · Cited by 16
Tunkel, A. R., van de Beek, D., & Scheld, W. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00084-9 · Cited by 27
Therapeutics for fulminant hepatitis caused by enteroviruses in neonates
Wang, L.-C., Tsai, H., Chen, S., & Wang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1014823 · Cited by 14
“However, the randomized, double-blinded, placebo-controlled studies show inconsistent efficacy in treating patients with EV meningitis or meningoencephalitis (Abzug et al., 2003; Desmond et al., 2006).”
BackgroundLaboratory diagnosis of CNS infections by molecular amplification techniques
Tang, Y. (2007) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.1.4.489 · Cited by 14
ASEPTIC MENINGITIS AND VIRAL MENINGITIS
Cherry, J. D., & Bronstein, D. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50046-7 · Cited by 15
Targeting the Virus Capsid as a Tool to Fight RNA Viruses
Hozáková, L., Vokatá, B., Ruml, T., & Ulbrich, P. (2022) · Viruses · doi:10.3390/v14020174 · Cited by 13
Neurologic Infectious Disease Emergencies
Pruitt, A. A. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.09.011 · Cited by 13
Coxsackieviruses, Echoviruses, and Numbered Enteroviruses
Romero, J. R., & Modlin, J. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00174-0 · Cited by 15
Roos, K. L., & Greenlee, J. (2011) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000407057.02414.a9 · Cited by 13
“duration of headache in enteroviral meningitis, but the drug is not routinely available.(5) Acyclovir is efficacious in treating herpes simplex virus type 2 (HSV-2) meningitis, and prophylactic therapy with acyclovir, valacyclovir, or famciclovir is efficacious in preventing recurrent meningitis due to HSV-2.”
Nervous System Complications of Systemic Viral Infections
Greenlee, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00043-6 · Cited by 14
The antiviral effect of jiadifenoic acids C against coxsackievirus B3
Ge, M., Wang, H., Zhang, G., Yu, S., & Li, Y. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.06.008 · Cited by 11
Upper Respiratory Infections in Adults
Kim, S. (2010) · Journal of Korean Medical Association · doi:10.5124/jkma.2010.53.1.10 · Cited by 11
Enterovirus and Parechovirus Infections
Cherry, J. D., & Krogstad, P. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00024-9 · Cited by 13
Introduction to the Human Enteroviruses and Parechoviruses
Romero, J. R., & Modlin, J. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00172-7 · Cited by 13
ENTEROVIRUSES AND PARECHOVIRUSES
Cherry, J. D., & Krogstad, P. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50183-7 · Cited by 11
Viral Infections of the Central Nervous System
Cassady, K. A., & Whitley, R. J. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch3 · Cited by 11
Self-citationRoux, H., Touret, F., Rathelot, P., Vanelle, P., & Roche, M. (2024) · Pharmaceuticals · doi:10.3390/ph17091218 · Cited by 10
“In 1999, three randomized, double-blind, placebo-controlled studies were performed to evaluate pleconaril efficacy against suspected EV meningitis or sepsis [32,34,40].”
BackgroundDexamethasone in adults with viral meningitis: an observational cohort study
Petersen, P. T., Bodilsen, J., Jepsen, M. P. G., Larsen, L., Storgaard, M., Hansen, B. R., Helweg‐Larsen, J., Wiese, L., Lüttichau, H. R., Andersen, C. Ø., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.08.015 · Cited by 11
Neuroinfections: Presentation, Diagnosis, and Treatment of Meningitis and Encephalitis
Bowers, K. M., & Mudrakola, V. (2020) · EMJ Neurology · doi:10.33590/emjneurol/20-00063 · Cited by 13
Bernard, A. M., Cabiddu, M. G., Montis, S. D., Mura, R., & Pompei, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.066 · Cited by 11
Emergency Department Approach to the Patient with Suspected Central Nervous System Infection
Jain, R., & Chang, W.-T. W. (2018) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2018.06.004 · Cited by 8
Viral Infections of the Fetus and Newborn
Schleiss, M. R., & Marsh, K. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00037-1 · Cited by 11
Paintsil, E., & Cheng, Y. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02387-4 · Cited by 10
Human parechovirus-3 infection mimicking Hirschsprung-associated enterocolitis
Watanabe, T., Takahashi, M., Shoji, K., Yamada, K., Yamada, W., Tanaka, H., Ishihama, H., Miyata, I., Saitoh, A., & Kanamori, Y. (2014) · Journal of Pediatric Surgery Case Reports · doi:10.1016/j.epsc.2014.01.001 · Cited by 7
“Pleconaril is the most advanced antiviral treatment option for enteroviruses, although only limited data on its efficacy for neonatal enterovirus disease have been presented [8].”
BackgroundViral infections of the central nervous system
Cassady, K. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00051-8 · Cited by 7
Time trends of viral meningitis among young adults in Israel: 1978–2012
Levine, H., Mimouni, D., Zurel-Farber, A., Zahavi, A., Molina-Hazan, V., Bar‐Zeev, Y., & Huerta-Hartal, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2057-3 · Cited by 8
“Nonpolio enteroviruses are common pathogens [13].”
Laconi, S., Madeddu, M. A., & Pompei, R. (2011) · Molecules · doi:10.3390/molecules16053479 · Cited by 8
“Pleconaril is a new-generation capsidblocker with a broad spectrum against several Enteroviruses and Rhinoviruses, but the presence of some important side-effects have blocked its clinical use [13,17].”
BackgroundChoi, I.-K., Lee, H.-K., Ji, Y.-J., Hwang, I.-H., & Kim, S. Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.4.241 · Cited by 8
Coxsackieviruses, Echoviruses, Newer Enteroviruses, and Parechoviruses
Modlin, J. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00172-7 · Cited by 7
Onarecker, T. R., & Romero, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00043-4 · Cited by 6
Enteroviruses, Parechoviruses, and Saffold Viruses
Krogstad, P. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00166-7 · Cited by 6
Higer, M., Cana, D., Podlech, J., Schadmand‐Fischer, S., Schwarting, A., Teschner, D., Theobald, M., Wölfel, T., & Heß, G. (2020) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02457-y · Cited by 6
Therapeutic advances in neuroinfectious diseases
Ardakani, R. V., Jia, L., Matthews, E., & Thakur, K. T. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241274246 · Cited by 8
Viral Central Nervous System Infections
Cassady, K. A., & Whitley, R. J. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch3 · Cited by 5
Self-citationProlonged Symptoms in Solid Organ Transplant Recipients with Enteroviral Meningitis
Kaul, S. J. (2013) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000116 · Cited by 4
“The natural history of enteroviral meningitis has been studied in adults [13,14].”
BackgroundBrouwer, M. C., & van de Beek, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00019-8 · Cited by 4
A Case Series on Enteroviral Meningitis in Pakistan
Jafri, L. A., Khan, A. F., Arshad, T., & Kanwar, D. (2021) · Cureus · doi:10.7759/cureus.19048 · Cited by 5
Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES)
Clercq, E. D. (2007) · Advances in antiviral drug design · doi:10.1016/s1075-8593(06)05002-7 · Cited by 3
Romero, J. R. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch46 · Cited by 3
Managing Infections in Patients With Hematological Malignancies
Kleinberg, M. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-415-5 · Cited by 5
Infections of the Central Nervous System
Blank, M. J. W., & Tunkel, A. R. (2012) · Wiley eBooks · doi:10.1002/9781119952930.ch117 · Cited by 3
Development of Enteroviral Aseptic Meningitis After Rituximab Treatment of Non-Hodgkin Lymphoma
Givens, P. M., Velez, A. P., Sandin, R. L., Quilitz, R. E., & Greene, J. N. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3182506ea0 · Cited by 2
“Although the risk of infection does not increase above expected with the 4- or 8-week course with rituximab compared to treatment without, the risk of infection almost doubles when rituximab is used for maintenance for follicular lymphoma.(12) Prolonged periods of B-cell deficiency caused by rituximab increase the ris…”
BackgroundMeningitis: Current Understanding and Management
Sharma, R. R., & Sharma, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813806-9.00001-9 · Cited by 2
Viral Infections of the Nervous System
Bale, J. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00104-9 · Cited by 4
Romero, J. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00043-x · Cited by 7
Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses
Clercq, E. D. (2007) · Advances in antiviral drug design · doi:10.1016/s1075-8593(06)05001-5 · Cited by 4
“39, 51 These compounds have been shown to specifically induce apoptosis in HPV-infected cells, which, in turn, may be related to their ability to restore the function of the tumor suppressor proteins p53 and pRb (which are neutralized by the oncoproteins E6 and E7, respectively, in HPV-infected cells).”
Background
Metadata
- Authors
- Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., & Whitley, R. J.
- Affiliations
- University of Alabama at Birmingham (US)
- Emmes (United States) (US)
- ViroPharma Incorporated, Exton, Pennsylvania
- Corresponding author
- Whitley, R. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-07
- Volume
- 50
- Issue
- 7
- Pages
- 2409-2414
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2016502913
- Cited by
- 154
- References
- 11
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 10 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 10
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai30025-8-0-2, n01ai065306-000, n01ai062554-008, n01ai015113-000)
- National Institute of Allergy and Infectious Diseases (N01-AI -15113, N01 AI 62554, N01 AI030025, N01‐AI‐65306)
- National Center for Research Resources (RR-032)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Keywords
- enteroviral meningitis, pleconaril, headache resolution, natural history of disease, antiviral therapy, nausea, sex differences in recovery, persistent headache
- MeSH terms
- Adult, Antiviral Agents, Double-Blind Method, Enterovirus Infections, Female, Headache, Humans, Male, Meningitis, Viral, Oxadiazoles, Oxazoles, Multivariate Analysis, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.